Actively Recruiting
Insomnia in Patients With Metastatic Lung Cancer
Led by Mayo Clinic · Updated on 2026-02-04
60
Participants Needed
1
Research Sites
414 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
CONDITIONS
Official Title
Insomnia in Patients With Metastatic Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a diagnosis of metastatic non small cell lung cancer
- Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy
- Older than 18 years old at the time of diagnosis
You will not qualify if you...
- Considered to have advanced terminal cancer
- Have severe depression or other psychiatric disorder
- Have a sleep disorder other than insomnia (e.g., sleep apnea, restless leg syndrome, sleep-related disorder of breathing)
- Regular use of psychotropic medication other than hypnotics (e.g., antidepressants) per chart review
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here